Additionally, we examined the tRF‐22–hnRNPAB–TGFβ2–PMN‐MDSCs–CD8+ T cells regulatory axis in ESCC patient specimens from those receiving immunotherapy. The gene discussed is HNRNPAB; the disease is esophageal squamous cell carcinoma.